2U, Inc. (TWOU) PT Raised to $83 at Oppenheimer

Oppenheimer analyst Brian Schwartz raised the price target on 2U, Inc. (NASDAQ: TWOU) to $83.00 (from $70.00) while maintaining a Outperform rating.

The analyst commented, "2U generated a beat and 2019 guide above in 4Q:2018 and displayed a 42% EBITDA margin for the oldest cohort (+300bps from last year). The reported results and EBITDA disclosure lend support to TWOU's valuation. Negatively, the magnitude of the quarter beats is diminishing from some lingering pressures on DGP enrollment and from large numbers. Nevertheless, we view the overall results and outlook as generally solid and supportive of our thesis that 2U has open-ended growth and is positioned for strong revenue growth and share gains in 2019. Bottom Line: We remain long-term positive on 2U given its leadership positioning and referenceability in a large TAM that's early in an attractive secular opportunity (i.e., digital learning disruption in higher education)."

You May Also Be Interested In

• Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
• Giant Biogene Holding Co (2367:HK) PT Raised to HK$46 at Macquarie
• Okta, Inc (OKTA) PT Raised to $170 at Cantor Fitzgerald Ahead of Q2 Results